Fig. 3.
D29 residual disease levels in relation to clinical outcome.
Scatterplot of MRD levels at D29 after the start of induction therapy and clinical outcome. The horizontal lines show the median levels at D29 for the patients in remission and the patients who developed a relapse, respectively.